In hepatocellular carcinoma, 53 IGF2BP3‐associated alternative splicing events have been identified,126 suggesting that IGF2BP3 may promote hepatocellular carcinoma progression through alternative splicing events that enrich multiple oncologic pathways.126. This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.